ALFA FinderNSE filing, NSE: C2C. Summary written from the filing by ALFA Finder's alert engine.
C2C Advanced Systems Ltd: key numbers
- Share price
- ₹150.40
- Market cap
- ₹250.3 Cr
- Revenue (annual)
- ₹145.6 Cr
- Net profit (annual)
- ₹18.33 Cr
- P/E (TTM)
- 13.7×Sector 51.9×
- Promoter holding
- 36.51%
- FII holding
- 2.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from C2C Advanced Systems Ltd
All →C2C Advanced Systems Management Change
C2C Advanced Systems Limited reported the resignation of Director Maya Chandra and the appointment of Putta Satish Chowdhary as an Additional Director, effective October 8, 2026.
C2C Advanced Systems Board Meeting Date
C2C Advanced Systems Limited intimated a board meeting on 08 October 2026 to consider other business. No specific material agenda items were disclosed.
C2C Advanced Systems Annual General Meeting
C2C Advanced Systems Limited held its 9th Annual General Meeting on September 30, 2026, transacting business related to financial statement adoption and various director appointments.
C2C Advanced Systems Business Update
CEO addresses shareholders regarding trade receivables collections and company operations. The letter also intimates the promoter group's intent to proceed with a future preferential allotment.
C2C Advanced Systems Annual General Meeting
C2C Advanced Systems Limited issued the notice for its 9th Annual General Meeting scheduled for September 30, 2026. The meeting agenda covers financial statements and director appointments.
C2C Advanced Systems Other Announcement
C2C Advanced Systems Limited has appointed M/s. Narasimhan & Srinivasan as Statutory Auditors of the Company, effective from September 07, 2026.
Other product launch announcements
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.